Founded in 1985 by five scientists, Buffalo-based ONY Biotech develops and manufactures neonatal therapies that help premature infants breathe, including the FDA-approved surfactant Infasurf® (calfactant). Privately held and led by founder Dr. Edmund Egan as chairman, the company has grown from research at a University at Buffalo incubator into a neonatology biotech with commercial products and a pipeline spanning neonatal respiratory and cardiovascular care.
PhRMA Code on Interactions with Healthcare Professionals
compliance_program
ONY California Compliance Declaration
compliance_program